{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["ADMET", "COVID-19", "DFT", "SARS-Cov-2 nsp10", "fingerprint", "molecular docking", "natural products", "structural similarity", "toxicity"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34684735", "DateCompleted": {"Year": "2021", "Month": "10", "Day": "27"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "07"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "12"}], "Language": ["eng"], "ELocationID": ["6151", "10.3390/molecules26206151"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "20", "PubDate": {"Year": "2021", "Month": "Oct", "Day": "12"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "<i>In Silico</i> Exploration of Potential Natural Inhibitors against SARS-Cov-2 nsp10.", "Abstract": {"AbstractText": ["In continuation of our previous effort, different <i>in silico</i> selection methods were applied to 310 naturally isolated metabolites that exhibited antiviral potentialities before. The applied selection methods aimed to pick the most relevant inhibitor of SARS-CoV-2 nsp10. At first, a structural similarity study against the co-crystallized ligand, S-Adenosyl Methionine (<b>SAM</b>), of SARS-CoV-2 nonstructural protein (nsp10) (PDB ID: 6W4H) was carried out. The similarity analysis culled 30 candidates. Secondly, a fingerprint study against <b>SAM</b> preferred compounds <b>44</b>, <b>48</b>, <b>85</b>, <b>102</b>, <b>105</b>, <b>182</b>, <b>220</b>, <b>221</b>, <b>282</b>, <b>284</b>, <b>285</b>, <b>301</b>, and <b>302</b>. The docking studies picked <b>48</b>, <b>182</b>, <b>220</b>, <b>221</b>, and <b>284</b>. While the ADMET analysis expected the likeness of the five candidates to be drugs, the toxicity study preferred compounds <b>48</b> and <b>182</b>. Finally, a density-functional theory (DFT) study suggested vidarabine (<b>182</b>) to be the most relevant SARS-Cov-2 nsp10 inhibitor."]}, "AuthorList": [{"Identifier": ["0000-0002-6955-2263"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Eissa", "ForeName": "Ibrahim H", "Initials": "IH"}, {"Identifier": ["0000-0002-8146-993X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Medicinal Chemistry & Drug Design Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Khalifa", "ForeName": "Mohamed M", "Initials": "MM"}, {"Identifier": ["0000-0002-2546-8035"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Almaarefa University, Riyadh 13713, Saudi Arabia."}], "LastName": "Elkaeed", "ForeName": "Eslam B", "Initials": "EB"}, {"Identifier": ["0000-0003-4044-5103"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Plant Protection and Biomolecular Diagnosis, ALCRI, City of Scientific Research and Technological Applications, New Borg El-Arab City 21934, Egypt."}], "LastName": "Hafez", "ForeName": "Elsayed E", "Initials": "EE"}, {"Identifier": ["0000-0003-4497-5013"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, Riyadh 11564, Saudi Arabia."}], "LastName": "Alsfouk", "ForeName": "Aisha A", "Initials": "AA"}, {"Identifier": ["0000-0001-8566-1980"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacognosy and Medicinal Plants Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Metwaly", "ForeName": "Ahmed M", "Initials": "AM"}], "GrantList": [{"GrantID": "Fast-track Research Funding program", "Agency": "eanship of Scientific Research at Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "NSP10 protein, SARS-CoV-2"}, {"RegistryNumber": "0", "NameOfSubstance": "Small Molecule Libraries"}, {"RegistryNumber": "0", "NameOfSubstance": "Viral Regulatory and Accessory Proteins"}, {"RegistryNumber": "7LP2MPO46S", "NameOfSubstance": "S-Adenosylmethionine"}, {"RegistryNumber": "FA2DM6879K", "NameOfSubstance": "Vidarabine"}], "MeshHeadingList": [{"QualifierName": ["chemistry", "metabolism", "therapeutic use"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": [], "DescriptorName": "Binding Sites"}, {"QualifierName": ["chemistry", "metabolism", "therapeutic use"], "DescriptorName": "Biological Products"}, {"QualifierName": ["pathology"], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "Density Functional Theory"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "S-Adenosylmethionine"}, {"QualifierName": ["isolation & purification", "metabolism"], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": ["chemistry", "metabolism", "therapeutic use"], "DescriptorName": "Small Molecule Libraries"}, {"QualifierName": ["chemistry", "metabolism", "therapeutic use"], "DescriptorName": "Vidarabine"}, {"QualifierName": ["antagonists & inhibitors", "metabolism"], "DescriptorName": "Viral Regulatory and Accessory Proteins"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "WHO  WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 2 September 2021)].  Available online:  https://covid19.who.int/"}, {"Citation": "Prieto-Mart\u00ednez F.D., L\u00f3pez-L\u00f3pez E., Ju\u00e1rez-Mercado K.E., Medina-Franco J.L. In Silico Drug Design. Elsevier; Amsterdam, The Netherlands: 2019. Computational drug design methods\u2014Current and future perspectives; pp. 19\u201344."}, {"Citation": "Nasser A.A., Eissa I.H., Oun M.R., El-Zahabi M.A., Taghour M.S., Belal A., Saleh A.M., Mehany A.B., Luesch H., Mostafa A.E., et al. Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFR WT and EGFR T790M. Org. Biomol. Chem. 2020;18:7608\u20137634. doi: 10.1039/D0OB01557A.", "ArticleIdList": ["10.1039/D0OB01557A", "32959865"]}, {"Citation": "Abbass E.M., Khalil A.K., Mohamed M.M., Eissa I.H., El-Naggar A.M. Design, efficient synthesis, docking studies, and anticancer evaluation of new quinoxalines as potential intercalative Topo II inhibitors and apoptosis inducers. Bioorg. Chem. 2020;104:104255. doi: 10.1016/j.bioorg.2020.104255.", "ArticleIdList": ["10.1016/j.bioorg.2020.104255", "32927130"]}, {"Citation": "Alanazi M.M., Mahdy H.A., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Dahab M.A., Eissa I.H. New bis ([1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4] triazolo)[4,3-a:3\u2032,4\u2032-c] quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation. Bioorg. Chem. 2021;112:104949.", "ArticleIdList": ["34023640"]}, {"Citation": "El-Helby A.-G.A., Sakr H., Ayyad R.R., Mahdy H.A., Khalifa M.M., Belal A., Rashed M., El-Sharkawy A., Metwaly A.M., Elhendawy M.A., et al. Design, synthesis, molecular modeling, in vivo studies and anticancer activity evaluation of new phthalazine derivatives as potential DNA intercalators and topoisomerase II inhibitors. Bioorg. Chem. 2020;103:104233. doi: 10.1016/j.bioorg.2020.104233.", "ArticleIdList": ["10.1016/j.bioorg.2020.104233", "32882440"]}, {"Citation": "Eissa I.H., Ibrahim M.K., Metwaly A.M., Belal A., Mehany A.B., Abdelhady A.A., Elhendawy M.A., Radwan M.M., ElSohly M.A., Mahdy H.A. Design, molecular docking, in vitro, and in vivo studies of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors with potential activity against hepatocellular carcinoma. Bioorg. Chem. 2021;107:104532. doi: 10.1016/j.bioorg.2020.104532.", "ArticleIdList": ["10.1016/j.bioorg.2020.104532", "33334586"]}, {"Citation": "Abo-Ashour M.F., Eldehna W.M., Nocentini A., Bonardi A., Bua S., Ibrahim H.S., Elaasser M.M., Kry\u0161tof V., Jorda R., Gratteri P., et al. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights. Eur. J. Med. Chem. 2019;184:111768. doi: 10.1016/j.ejmech.2019.111768.", "ArticleIdList": ["10.1016/j.ejmech.2019.111768", "31629164"]}, {"Citation": "Marrone T.J., Briggs A., James M., McCammon J.A. Structure-based drug design: Computational advances. Annu. Rev. Pharmacol. Toxicol. 1997;37:71\u201390. doi: 10.1146/annurev.pharmtox.37.1.71.", "ArticleIdList": ["10.1146/annurev.pharmtox.37.1.71", "9131247"]}, {"Citation": "Li N., Wang Y., Li W., Li H., Yang L., Wang J., Mahdy H.A., Mehany A., Jaiash D.A., Santali E.Y., et al. Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer\u2019s Agents Targeting BACE1 and PPAR\u03b3. J. Chem. 2020;2020:1631243. doi: 10.1155/2020/1631243.", "ArticleIdList": ["10.1155/2020/1631243"]}, {"Citation": "Abdel-Aziz H.A., Eldehna W.M., Fares M., Al-Rashood S.T., Al-Rashood K.A., Abdel-Aziz M.M., Soliman D.H. Synthesis, biological evaluation and 2D-QSAR study of halophenyl bis-hydrazones as antimicrobial and antitubercular agents. Int. J. Mol. Sci. 2015;16:8719\u20138743. doi: 10.3390/ijms16048719.", "ArticleIdList": ["10.3390/ijms16048719", "PMC4425105", "25903147"]}, {"Citation": "Kairys V., Baranauskiene L., Kazlauskiene M., Matulis D., Kazlauskas E. Binding affinity in drug design: Experimental and computational techniques. Expert Opin. Drug Discov. 2019;14:755\u2013768. doi: 10.1080/17460441.2019.1623202.", "ArticleIdList": ["10.1080/17460441.2019.1623202", "31146609"]}, {"Citation": "Al-Warhi T., El Kerdawy A.M., Aljaeed N., Ismael O.E., Ayyad R.R., Eldehna W.M., Abdel-Aziz H.A., Al-Ansary G.H. Synthesis, biological evaluation and in silico studies of certain oxindole\u2013indole conjugates as anticancer CDK inhibitors. Molecules. 2020;25:2031. doi: 10.3390/molecules25092031.", "ArticleIdList": ["10.3390/molecules25092031", "PMC7248897", "32349307"]}, {"Citation": "El-Metwally S.A., Abou-El-Regal M.M., Eissa I.H., Mehany A.B., Mahdy H.A., Elkady H., Elwan A., Elkaeed E.B. Discovery of thieno [2,3-d] pyrimidine-based derivatives as potent VEGFR-2 kinase inhibitors and anti-cancer agents. Bioorg. Chem. 2021;112:104947. doi: 10.1016/j.bioorg.2021.104947.", "ArticleIdList": ["10.1016/j.bioorg.2021.104947", "33964580"]}, {"Citation": "Alanazi M.M., Eissa I.H., Alsaif N.A., Obaidullah A.J., Alanazi W.A., Alasmari A.F., Albassam H., Elkady H., Elwan A. Design, synthesis, docking, ADMET studies, and anticancer evaluation of new 3-methylquinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1760\u20131782. doi: 10.1080/14756366.2021.1956488.", "ArticleIdList": ["10.1080/14756366.2021.1956488", "PMC8344243", "34340610"]}, {"Citation": "Alanazi M.M., Alaa E., Alsaif N.A., Obaidullah A.J., Alkahtani H.M., Al-Mehizia A.A., Alsubaie S.M., Taghour M.S., Eissa I.H. Discovery of new 3-methylquinoxalines as potential anti-cancer agents and apoptosis inducers targeting VEGFR-2: Design, synthesis, and in silico studies. J. Enzym. Inhib. Med. Chem. 2021;36:1732\u20131750. doi: 10.1080/14756366.2021.1945591.", "ArticleIdList": ["10.1080/14756366.2021.1945591", "PMC8330740", "34325596"]}, {"Citation": "Alsaif N.A., Taghour M.S., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Elwan A., Elkady H. Discovery of new VEGFR-2 inhibitors based on bis ([1,2,4]triazolo)[4,3-a: 3\u2032,4\u2032-c] quinoxaline derivatives as anticancer agents and apoptosis inducers. J. Enzym. Inhib. Med. Chem. 2021;36:1093\u20131114. doi: 10.1080/14756366.2021.1915303.", "ArticleIdList": ["10.1080/14756366.2021.1915303", "PMC8168755", "34056992"]}, {"Citation": "Alsaif N.A., Dahab M.A., Alanazi M.M., Obaidullah A.J., Al-Mehizia A.A., Alanazi M.M., Aldawas S., Mahdy H.A., Elkady H. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis. Bioorg. Chem. 2021;110:104807. doi: 10.1016/j.bioorg.2021.104807.", "ArticleIdList": ["10.1016/j.bioorg.2021.104807", "33721808"]}, {"Citation": "El-Adl K., Ibrahim M.-K., Alesawy M.S., Eissa I.H. [1,2,4]Triazolo [4,3-c]quinazoline and bis([1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4][1,2,4]triazolo)[4,3-a:4\u2032,3\u2032-c] quinazoline derived DNA intercalators: Design, synthesis, in silico ADMET profile, molecular docking and anti-proliferative evaluation studies. Bioorg. Med. Chem. 2021;30:115958.", "ArticleIdList": ["33360576"]}, {"Citation": "March-Vila E., Pinzi L., Sturm N., Tinivella A., Engkvist O., Chen H., Rastelli G. On the integration of in silico drug design methods for drug repurposing. Front. Pharmacol. 2017;8:298. doi: 10.3389/fphar.2017.00298.", "ArticleIdList": ["10.3389/fphar.2017.00298", "PMC5440551", "28588497"]}, {"Citation": "Zhang W., Pei J., Lai L. Computational multitarget drug design. J. Chem. Inf. Model. 2017;57:403\u2013412. doi: 10.1021/acs.jcim.6b00491.", "ArticleIdList": ["10.1021/acs.jcim.6b00491", "28166637"]}, {"Citation": "Youssef M.I., Zhou Y., Eissa I.H., Wang Y., Zhang J., Jiang L., Hu W., Qi J., Chen Z. Tetradecyl 2,3-dihydroxybenzoate alleviates oligodendrocyte damage following chronic cerebral hypoperfusion through IGF-1 receptor. Neurochem. Int. 2020;138:104749. doi: 10.1016/j.neuint.2020.104749.", "ArticleIdList": ["10.1016/j.neuint.2020.104749", "32387468"]}, {"Citation": "Zhong F., Xing J., Li X., Liu X., Fu Z., Xiong Z., Lu D., Wu X., Zhao J., Tan X. Artificial intelligence in drug design. Sci. China Life Sci. 2018;61:1191\u20131204. doi: 10.1007/s11427-018-9342-2.", "ArticleIdList": ["10.1007/s11427-018-9342-2", "30054833"]}, {"Citation": "Hagras M., El Deeb M.A., Elzahabi H.S., Elkaeed E.B., Mehany A.B., Eissa I.H. Discovery of new quinolines as potent colchicine binding site inhibitors: Design, synthesis, docking studies, and anti-proliferative evaluation. J. Enzym. Inhib. Med. Chem. 2021;36:640\u2013658. doi: 10.1080/14756366.2021.1883598.", "ArticleIdList": ["10.1080/14756366.2021.1883598", "PMC7889231", "33588683"]}, {"Citation": "Eissa I.H., Dahab M.A., Ibrahim M.K., Alsaif N.A., Alanazi A., Eissa S.I., Mehany A.B., Beauchemin A.M. Design and discovery of new antiproliferative 1,2,4-triazin-3 (2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site. Bioorg. Chem. 2021;112:104965. doi: 10.1016/j.bioorg.2021.104965.", "ArticleIdList": ["10.1016/j.bioorg.2021.104965", "34020238"]}, {"Citation": "Eissa I.H., El-Helby A.-G.A., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., ElSohly M.A., et al. Discovery of new quinazolin-4 (3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation. Bioorg. Chem. 2020;105:104380. doi: 10.1016/j.bioorg.2020.104380.", "ArticleIdList": ["10.1016/j.bioorg.2020.104380", "33128967"]}, {"Citation": "El-Adl K., El-Helby A.-G.A., Ayyad R.R., Mahdy H.A., Khalifa M.M., Elnagar H.A., Mehany A.B., Metwaly A.M., Elhendawy M.A., Radwan M.M., et al. Design, synthesis, and anti-proliferative evaluation of new quinazolin-4 (3H)-ones as potential VEGFR-2 inhibitors. Bioorg. Med. Chem. 2021;29:115872. doi: 10.1016/j.bmc.2020.115872.", "ArticleIdList": ["10.1016/j.bmc.2020.115872", "33214036"]}, {"Citation": "Hopfinger A. Computer-assisted drug design. J. Med. Chem. 1985;28:1133\u20131139. doi: 10.1021/jm00147a001.", "ArticleIdList": ["10.1021/jm00147a001", "2993608"]}, {"Citation": "Jalmakhanbetova R.I., Suleimen Y.M., Oyama M., Elkaeed E.B., Eissa I., Suleimen R.N., Metwaly A.M., Ishmuratova M.Y. Isolation and In Silico Anti-COVID-19 Main Protease (Mpro) Activities of Flavonoids and a Sesquiterpene Lactone from Artemisia sublessingiana. J. Chem. 2021;2021:13. doi: 10.1155/2021/5547013.", "ArticleIdList": ["10.1155/2021/5547013"]}, {"Citation": "Al-Karmalawy A.A., Dahab M.A., Metwaly A.M., Elhady S.S., Elkaeed E.B., Eissa I.H., Darwish K.M. Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor. Front. Chem. 2021;9:661230. doi: 10.3389/fchem.2021.661230.", "ArticleIdList": ["10.3389/fchem.2021.661230", "PMC8129187", "34017819"]}, {"Citation": "Alesawy M.S., Abdallah A.E., Taghour M.S., Elkaeed E.B., Eissa I.H., Metwaly A.M. In Silico Studies of Some Isoflavonoids as Potential Candidates against COVID-19 Targeting Human ACE2 (hACE2) and Viral Main Protease (Mpro) Molecules. 2021;26:2806. doi: 10.3390/molecules26092806.", "ArticleIdList": ["10.3390/molecules26092806", "PMC8126168", "34068579"]}, {"Citation": "El-Demerdash A., Metwaly A.M., Hassan A., El-Aziz A., Mohamed T., Elkaeed E.B., Eissa I.H., Arafa R.K., Stockand J.D. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19) Biomolecules. 2021;11:460. doi: 10.3390/biom11030460.", "ArticleIdList": ["10.3390/biom11030460", "PMC8003478", "33808721"]}, {"Citation": "Metwaly A.M., Ghoneim M.M., Eissa I.H., Elsehemy I.A., Mostafa A.E., Hegazy M.M., Afifi W.M., Dou D. Traditional ancient Egyptian medicine: A review. Saudi J. Biol. Sci. 2021;28:5823\u20135832. doi: 10.1016/j.sjbs.2021.06.044.", "ArticleIdList": ["10.1016/j.sjbs.2021.06.044", "PMC8459052", "34588897"]}, {"Citation": "Han X., Yang Y., Metwaly A.M., Xue Y., Shi Y., Dou D. The Chinese herbal formulae (Yitangkang) exerts an antidiabetic effect through the regulation of substance metabolism and energy metabolism in type 2 diabetic rats. J. Ethnopharmacol. 2019;239:111942. doi: 10.1016/j.jep.2019.111942.", "ArticleIdList": ["10.1016/j.jep.2019.111942", "31075380"]}, {"Citation": "Metwaly A.M., Zhu L., Huang L., Dou D. Black ginseng and its saponins: Preparation, phytochemistry and pharmacological effects. Molecules. 2019;24:1856. doi: 10.3390/molecules24101856.", "ArticleIdList": ["10.3390/molecules24101856", "PMC6572638", "31091790"]}, {"Citation": "Wang Y.-M., Ran X.-K., Riaz M., Yu M., Cai Q., Dou D.-Q., Metwaly A.M., Kang T.-G., Cai D.-C. Chemical constituents of stems and leaves of Tagetespatula L. and its fingerprint. Molecules. 2019;24:3911. doi: 10.3390/molecules24213911.", "ArticleIdList": ["10.3390/molecules24213911", "PMC6864839", "31671631"]}, {"Citation": "Metwaly A. Comparative biological evaluation of four endophytic fungi isolated from nigella sativa seeds. Al-Azhar J. Pharm. Sci. 2019;59:123\u2013136. doi: 10.21608/ajps.2019.64111.", "ArticleIdList": ["10.21608/ajps.2019.64111"]}, {"Citation": "Metwaly A.M., Wanas A.S., Radwan M.M., Ross S.A., ElSohly M.A. New \u03b1-Pyrone derivatives from the endophytic fungus Embellisia sp. Med. Chem. Res. 2017;26:1796\u20131800. doi: 10.1007/s00044-017-1889-7.", "ArticleIdList": ["10.1007/s00044-017-1889-7"]}, {"Citation": "Metwaly A.M., Kadry H.A., Atef A., Mohammad A.-E.I., Ma G., Cutler S.J., Ross S.A. Nigrosphaerin A a new isochromene derivative from the endophytic fungus Nigrospora sphaerica. Phytochem. Lett. 2014;7:1\u20135. doi: 10.1016/j.phytol.2013.09.001.", "ArticleIdList": ["10.1016/j.phytol.2013.09.001", "PMC5047436", "27708743"]}, {"Citation": "Metwaly A.M., Fronczek F.R., Ma G., Kadry H.A., Atef A., Mohammad A.-E.I., Cutler S.J., Ross S.A. Antileukemic \u03b1-pyrone derivatives from the endophytic fungus Alternaria phragmospora. Tetrahedron Lett. 2014;55:3478\u20133481. doi: 10.1016/j.tetlet.2014.04.085.", "ArticleIdList": ["10.1016/j.tetlet.2014.04.085", "PMC5047437", "27708462"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Falodun A. Comprehensive In Silico Screening of the Antiviral Potentialities of a New Humulene Glucoside from Asteriscus hierochunticus against SARS-CoV-2. J. Chem. 2021;2021:5541876. doi: 10.1155/2021/5541876.", "ArticleIdList": ["10.1155/2021/5541876"]}, {"Citation": "Zhanzhaxina A., Suleimen Y., Metwaly A.M., Eissa I.H., Elkaeed E.B., Suleimen R., Ishmuratova M., Akatan K., Luyten W. In Vitro and In Silico Cytotoxic and Antibacterial Activities of a Diterpene from Cousinia alata Schrenk. J. Chem. 2021;2021:5542455. doi: 10.1155/2021/5542455.", "ArticleIdList": ["10.1155/2021/5542455"]}, {"Citation": "Imieje V.O., Zaki A.A., Metwaly A.M., Eissa I.H., Elkaeed E.B., Ali Z., Khan I.A., Falodun A. Antileishmanial Derivatives of Humulene from Asteriscus hierochunticus with in silico Tubulin Inhibition Potential. Rec. Nat. Prod. 2021;16:150\u2013171."}, {"Citation": "Jalmakhanbetova R., Elkaeed E.B., Eissa I.H., Metwaly A.M., Suleimen Y.M. Synthesis and Molecular Docking of Some Grossgemin Amino Derivatives as Tubulin Inhibitors Targeting Colchicine Binding Site. J. Chem. 2021;2021:5586515. doi: 10.1155/2021/5586515.", "ArticleIdList": ["10.1155/2021/5586515"]}, {"Citation": "Suleimen Y.M., Metwaly A.M., Mostafa A.E., Elkaeed E.B., Liu H.-W., Basnet B.B., Suleimen R.N., Ishmuratova M.Y., Turdybekov K.M., Van He\u0441ke K. Isolation, Crystal Structure, and In Silico Aromatase Inhibition Activity of Ergosta-5,22-dien-3\u03b2-ol from the Fungus Gyromitra esculenta. J. Chem. 2021;2021:5529786. doi: 10.1155/2021/5529786.", "ArticleIdList": ["10.1155/2021/5529786"]}, {"Citation": "Ghoneim M.M., Afifi W.M., Ibrahim M., Elagawany M., Khayat M.T., Aboutaleb M.H., Metwaly A.M. Biological evaluation and molecular docking study of metabolites from Salvadora persica L. Growing in Egypt. Pharmacogn. Mag. 2019;15:232."}, {"Citation": "Liu L., Luo S., Yu M., Metwaly A.M., Ran X., Ma C., Dou D., Cai D. Chemical Constituents of Tagetes patula and Their Neuroprotecting Action. Nat. Prod. Commun. 2020;15:1934578X20974507."}, {"Citation": "Metwaly A.M., Ghoneim M.M., Musa A. Two new antileishmanial diketopiperazine alkaloids from the endophytic fungus Trichosporum sp. Derpharmachemica. 2015;7:322\u2013327."}, {"Citation": "Yassin A.M., El-Deeb N.M., Metwaly A.M., El Fawal G.F., Radwan M.M., Hafez E.E. Induction of apoptosis in human cancer cells through extrinsic and intrinsic pathways by Balanites aegyptiaca furostanol saponins and saponin-coated silvernanoparticles. Appl. Biochem. Biotechnol. 2017;182:1675\u20131693. doi: 10.1007/s12010-017-2426-3.", "ArticleIdList": ["10.1007/s12010-017-2426-3", "28236195"]}, {"Citation": "Sharaf M.H., El-Sherbiny G.M., Moghannem S.A., Abdelmonem M., Elsehemy I.A., Metwaly A.M., Kalaba M.H. New combination approaches to combat methicillin-resistant Staphylococcus aureus (MRSA) Sci. Rep. 2021;11:4240. doi: 10.1038/s41598-021-82550-4.", "ArticleIdList": ["10.1038/s41598-021-82550-4", "PMC7896049", "33608582"]}, {"Citation": "Lin S., Chen H., Chen Z., Yang F., Ye F., Zheng Y., Yang J., Lin X., Sun H., Wang L., et al. Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity. Nucleic Acids Res. 2021;49:5382\u20135392. doi: 10.1093/nar/gkab320.", "ArticleIdList": ["10.1093/nar/gkab320", "PMC8136770", "33956156"]}, {"Citation": "Lin S., Chen H., Ye F., Chen Z., Yang F., Zheng Y., Cao Y., Qiao J., Yang S., Lu G. Crystal structure of SARS-CoV-2 nsp10/nsp16 2\u2032-O-methylase and its implication on antiviral drug design. Signal Transduct. Target. Ther. 2020;5:131. doi: 10.1038/s41392-020-00241-4.", "ArticleIdList": ["10.1038/s41392-020-00241-4", "PMC7388121", "32728018"]}, {"Citation": "Tazikeh-Lemeski E., Moradi S., Raoufi R., Shahlaei M., Janlou M.A.M., Zolghadri S. Targeting SARS-COV-2 non-structural protein 16: A virtual drug repurposing study. J. Biomol. Struct. Dyn. 2020;39:4633\u20134646. doi: 10.1080/07391102.2020.1779133.", "ArticleIdList": ["10.1080/07391102.2020.1779133", "PMC7332864", "32573355"]}, {"Citation": "Yadav R., Parihar R.D., Dhiman U., Dhamija P., Kumar S. Docking of fda approved drugs targeting nsp-16, n-protein and main protease of sars-cov-2 as dual inhibitors. Biointerface Res. Appl. Chem. 2020;11:9848\u20139861."}, {"Citation": "Parida P.K., Paul D., Chakravorty D. Nature\u2019s therapy for COVID-19: Targeting the vital non-structural proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants. Phytomed. Plus. 2021;1:100002. doi: 10.1016/j.phyplu.2020.100002.", "ArticleIdList": ["10.1016/j.phyplu.2020.100002", "PMC7691168", "35403083"]}, {"Citation": "Nasser M., Salim N., Hamza H., Saeed F., Rabiu I. Improved deep learning based method for molecular similarity searching using stack of deep belief networks. Molecules. 2021;26:128. doi: 10.3390/molecules26010128.", "ArticleIdList": ["10.3390/molecules26010128", "PMC7795308", "33383976"]}, {"Citation": "Turchi M., Cai Q., Lian G. An evaluation of in-silico methods for predicting solute partition in multiphase complex fluids\u2013A case study of octanol/water partition coefficient. Chem. Eng. Sci. 2019;197:150\u2013158. doi: 10.1016/j.ces.2018.12.003.", "ArticleIdList": ["10.1016/j.ces.2018.12.003"]}, {"Citation": "Sullivan K.M., Enoch S.J., Ezendam J., Sewald K., Roggen E.L., Cochrane S. An adverse outcome pathway for sensitization of the respiratory tract by low-molecular-weight chemicals: Building evidence to support the utility of in vitro and in silico methods in a regulatory context. Applied In Vitro Toxicology. 2017;3:213\u2013226. doi: 10.1089/aivt.2017.0010.", "ArticleIdList": ["10.1089/aivt.2017.0010"]}, {"Citation": "Altamash T., Amhamed A., Aparicio S., Atilhan M. Effect of hydrogen bond donors and acceptors on CO2 absorption by deep eutectic solvents. Processes. 2020;8:1533. doi: 10.3390/pr8121533.", "ArticleIdList": ["10.3390/pr8121533"]}, {"Citation": "Wan Y., Tian Y., Wang W., Gu S., Ju X., Liu G. In silico studies of diarylpyridine derivatives as novel HIV-1 NNRTIs using docking-based 3D-QSAR, molecular dynamics, and pharmacophore modeling approaches. RSC Adv. 2018;8:40529\u201340543. doi: 10.1039/C8RA06475J.", "ArticleIdList": ["10.1039/C8RA06475J", "PMC9091378", "35557880"]}, {"Citation": "Escamilla-Guti\u00e9rrez A., Ribas-Aparicio R.M., C\u00f3rdova-Espinoza M.G., Castel\u00e1n-Vega J.A. In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets. Nucleosides Nucleotides Nucleic Acids. 2021;40:798\u2013807. doi: 10.1080/15257770.2021.1951754.", "ArticleIdList": ["10.1080/15257770.2021.1951754", "34323642"]}, {"Citation": "Kaushik A.C., Kumar A., Bharadwaj S., Chaudhary R., Sahi S. Bioinformatics Techniques for Drug Discovery. Springer; Berlin, Germany: 2018. Ligand-Based Approach for In-silico Drug Designing; pp. 11\u201319."}, {"Citation": "Zhang H., Ren J.-X., Ma J.-X., Ding L. Development of an in silico prediction model for chemical-induced urinary tract toxicity by using na\u00efve Bayes classifier. Mol. Divers. 2019;23:381\u2013392. doi: 10.1007/s11030-018-9882-8.", "ArticleIdList": ["10.1007/s11030-018-9882-8", "30294757"]}, {"Citation": "Willett P. Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today. 2006;11:1046\u20131053. doi: 10.1016/j.drudis.2006.10.005.", "ArticleIdList": ["10.1016/j.drudis.2006.10.005", "17129822"]}, {"Citation": "Ieritano C., Campbell J.L., Hopkins W.S. Predicting differential ion mobility behaviour in silico using machine learning. Analyst. 2021;146:4737\u20134743. doi: 10.1039/D1AN00557J.", "ArticleIdList": ["10.1039/D1AN00557J", "34212943"]}, {"Citation": "Taha M., Ismail N.H., Ali M., Rashid U., Imran S., Uddin N., Khan K.M. Molecular hybridization conceded exceptionally potent quinolinyl-oxadiazole hybrids through phenyl linked thiosemicarbazide antileishmanial scaffolds: In silico validation and SAR studies. Bioorg. Chem. 2017;71:192\u2013200. doi: 10.1016/j.bioorg.2017.02.005.", "ArticleIdList": ["10.1016/j.bioorg.2017.02.005", "28228228"]}, {"Citation": "Chu H., He Q.-X., Wang J., Hu Y., Wang Y.-Q., Lin Z.-H. In silico design of novel benzohydroxamate-based compounds as inhibitors of histone deacetylase 6 based on 3D-QSAR, molecular docking, and molecular dynamics simulations. New J. Chem. 2020;44:21201\u201321210. doi: 10.1039/D0NJ04704J.", "ArticleIdList": ["10.1039/D0NJ04704J"]}, {"Citation": "Opo F.A.D.M., Rahman M.M., Ahammad F., Ahmed I., Bhuiyan M.A., Asiri A.M. Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein. Sci. Rep. 2021;11:4049. doi: 10.1038/s41598-021-83626-x.", "ArticleIdList": ["10.1038/s41598-021-83626-x", "PMC7892887", "33603068"]}, {"Citation": "Fleming I. Frontier Orbitals and Organic Chemical Reactions. Wiley; Hoboken, NJ, USA: 1977."}, {"Citation": "El-Nahass M., Kamel M., El-Deeb A., Atta A., Huthaily S. Ab initio HF, DFT and experimental (FT-IR) investigation of vibrational spectroscopy of PN, N-dimethylaminobenzylidenemalononitrile (DBM) Spectrochim. Acta Part. A Mol. Biomol. Spectrosc. 2011;79:443\u2013450. doi: 10.1016/j.saa.2011.02.055.", "ArticleIdList": ["10.1016/j.saa.2011.02.055", "21514212"]}, {"Citation": "Suhasini M., Sailatha E., Gunasekaran S., Ramkumaar G. Vibrational and electronic investigations, thermodynamic parameters, HOMO and LUMO analysis on Lornoxicam by density functional theory. J. Mol. Struct. 2015;1100:116\u2013128. doi: 10.1016/j.molstruc.2015.07.003.", "ArticleIdList": ["10.1016/j.molstruc.2015.07.003"]}, {"Citation": "Bitencourt-Ferreira G., de Azevedo Junior W.F. Electrostatic Potential Energy in Protein-Drug Complexes. Curr. Med. Chem. 2021;28:4954\u20134971. doi: 10.2174/0929867328666210201150842.", "ArticleIdList": ["10.2174/0929867328666210201150842", "33593246"]}, {"Citation": "Matin M.M., Hasan M.S., Uzzaman M., Bhuiyan M.M.H., Kibria S.M., Hossain M.E., Roshid M.H. Synthesis, spectroscopic characterization, molecular docking, and ADMET studies of mannopyranoside esters as antimicrobial agents. J. Mol. Struct. 2020;1222:128821. doi: 10.1016/j.molstruc.2020.128821.", "ArticleIdList": ["10.1016/j.molstruc.2020.128821"]}, {"Citation": "Whitley R.J., Alford C.A., Hirsch M.S., Schooley R.T., Luby J.P., Aoki F.Y., Hanley D., Nahmias A.J., Soong S.-J., NIAID Collaborative Antiviral Study Group Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N. Engl. J. Med. 1986;314:144\u2013149. doi: 10.1056/NEJM198601163140303.", "ArticleIdList": ["10.1056/NEJM198601163140303", "3001520"]}, {"Citation": "Whitley R.J., Nahmias A.J., Soong S.-J., Galasso G.G., Fleming C.L., Alford C.A., Connor J., Bryson Y., Linnemann C. Vidarabine therapy of neonatal herpes simplex virus infection. Pediatrics. 1980;66:495\u2013501.", "ArticleIdList": ["7001331"]}, {"Citation": "Pollard R.B., Smith J.L., Neal E.A., Gregory P.B., Merigan T.C., Robinson W.S. Effect of vidarabine on chronic hepatitis B virus infection. JAMA. 1978;239:1648\u20131650. doi: 10.1001/jama.1978.03280430064020.", "ArticleIdList": ["10.1001/jama.1978.03280430064020", "633577"]}, {"Citation": "Miwa N., Kurosaki K., Yoshida Y., Kurokawa M., Saito S., Shiraki K. Comparative efficacy of acyclovir and vidarabine on the replication of varicella-zoster virus. Antivir. Res. 2005;65:49\u201355. doi: 10.1016/j.antiviral.2004.10.002.", "ArticleIdList": ["10.1016/j.antiviral.2004.10.002", "15652971"]}, {"Citation": "Chapman C., Flower A., Durrant S. The use of vidarabine in the treatment of human polyomavirus associated acute haemorrhagic cystitis. Bone Marrow Transplant. 1991;7:481\u2013483.", "ArticleIdList": ["1651795"]}, {"Citation": "Kurosaki K., Miwa N., Yoshida Y., Kurokawa M., Kurimoto M., Endo S., Shiraki K. Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis. Antivir. Chem. Chemother. 2004;15:281\u2013285. doi: 10.1177/095632020401500507.", "ArticleIdList": ["10.1177/095632020401500507", "15535050"]}, {"Citation": "Kimura H., Morita M., Tsuge I., Hoshino Y., Tanaka N., Ito Y., Morishima T. Vidarabine therapy for severe chronic active Epstein\u2013Barr virus infection. J. Pediatric Hematol. Oncol. 2001;23:294\u2013299. doi: 10.1097/00043426-200106000-00012.", "ArticleIdList": ["10.1097/00043426-200106000-00012", "11464986"]}, {"Citation": "Yousef R., Sakr H., Eissa I., Mehany A., Metwaly A., Elhendawy M.A., Radwan M., ElSohly M.A., Abulkhair H.S., El-Adl K. New quinoxaline-2 (1H)-ones as potential VEGFR-2 inhibitors: Design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 2021;45:16949\u201316964. doi: 10.1039/D1NJ02509K.", "ArticleIdList": ["10.1039/D1NJ02509K", "34175720"]}, {"Citation": "Amer H.H., Alotaibi S.H., Trawneh A.H., Metwaly A.M., Eissa I.H. Anticancer activity, spectroscopic and molecular docking of some new synthesized sugar hydrazones, Arylidene and \u03b1-Aminophosphonate derivatives. Arab. J. Chem. 2021;14:103348. doi: 10.1016/j.arabjc.2021.103348.", "ArticleIdList": ["10.1016/j.arabjc.2021.103348"]}, {"Citation": "Alesawy M.S., Al-Karmalawy A.A., Elkaeed E.B., Alswah M., Belal A., Taghour M.S., Eissa I.H. Design and discovery of new 1,2,4-triazolo [4,3-c] quinazolines as potential DNA intercalators and topoisomerase II inhibitors. Arch. Pharm. 2021;354:2000237. doi: 10.1002/ardp.202000237.", "ArticleIdList": ["10.1002/ardp.202000237", "33226150"]}, {"Citation": "Parmar D.R., Soni J.Y., Guduru R., Rayani R.H., Kusurkar R.V., Vala A.G., Talukdar S.N., Eissa I.H., Metwaly A.M., Khalil A., et al. Discovery of new anticancer thiourea-azetidine hybrids: Design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studies. Bioorg. Chem. 2021;115:105206. doi: 10.1016/j.bioorg.2021.105206.", "ArticleIdList": ["10.1016/j.bioorg.2021.105206", "34339975"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "9", "Day": "9"}, {"Year": "2021", "Month": "9", "Day": "30"}, {"Year": "2021", "Month": "10", "Day": "6"}, {"Year": "2021", "Month": "10", "Day": "23", "Hour": "1", "Minute": "19"}, {"Year": "2021", "Month": "10", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "10", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["34684735", "PMC8539059", "10.3390/molecules26206151", "molecules26206151"]}}], "PubmedBookArticle": []}